SCHEMBL19917

SCHEMBL19917

COc1[c]cc(Cl)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9111454 0.77 PTPN1 (0.32)
SCHEMBL162984 0.76 NQO1 (0.36)
SCHEMBL159912 0.76 ADRB2 (0.31)
SCHEMBL359290 0.76 HTR2C (0.35)
SCHEMBL358869 0.74 KDM4E (0.36)
SCHEMBL160506 0.73
SCHEMBL105204 0.73 CA1 (0.48)
SCHEMBL9652575 0.73 MAOA (0.45)
SCHEMBL3958751 0.73 TTR (0.36)
SCHEMBL24397 0.73 CA1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3194 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120442-A1 PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) 2024-06-13 WO claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 US claimed
CN-118055930-A Thiadiazole derivative, composition and application thereof 北京丹擎医药科技有限公司 2024-05-17 CN claimed
US-20230183248-A1 PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY JANSSEN PHARMACEUTICA NV (BE) 2023-06-15 US claimed
EP-3720858-B1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARM INC (US) 2023-06-07 EP claimed
WO-2023061415-A1 THIADIAZOLYL DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2023-04-20 WO claimed
EP-4135842-A1 PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY JANSSEN Pharmaceutica NV (BE) 2023-02-22 EP claimed
CN-115485026-A Pyrazolo [1,2-D ] [1,2,4] triazin-2-yl-acetamides as NLRP3 inflammatory pathway inhibitors 詹森药业有限公司 2022-12-16 CN claimed
US-20220396579-A1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. 2022-12-15 US claimed
CN-107879975-B Histone deacetylase inhibitor and application thereof 中国科学院上海药物研究所 2022-07-26 CN claimed
US-4696675-A Process for preparing water-insoluble blue azo dyes on the fiber: hydroxynaphthoic amide and diazotized di-alkoxy-benzidine HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-29 US claimed
EP-0199973-A2 Process for the production on the fibre of water insoluble azo dyes HOECHST AKTIENGESELLSCHAFT (DE) 1986-11-05 EP claimed
EP-0091193-B1 ANTIDIABETIC COMPOSITIONS PFIZER INC. (US) 1986-05-21 EP claimed
EP-0091193-A2 Antidiabetic compositions PFIZER INC. (US) 1983-10-12 EP claimed
US-4159983-A Pure and substantially pure asymmetric 1:2 cobalt complexes of monoazo compounds SANDOZ LTD. (CH) 1979-07-03 US claimed
US-4051156-A N-(triaryl-methyl)-amidines, process for the preparation thereof and compositions containing the same CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT (HU) 1977-09-27 US claimed
US-4041036-A NAPHTHO(1',2':5,6)-PYRANO(2,3-D)PYRIMIDINE DYES HOECHST AKTIENGESELLSCHAFT (DT) 1977-08-09 US claimed
US-4029666-A Benzenesulfonyl-ureas and process for preparing them HOECHST AKTIENGESELLSCHAFT (DT) 1977-06-14 US claimed
US-3953449-A ANALGESICS SYNTHELABO (FR) 1976-04-27 US claimed
US-3932503-A Benzenesulfonyl ureas HOECHST AKTIENGESELLSCHAFT (DT) 1976-01-13 US claimed